Factors related to loss of HIV-specific cytotoxic T lymphocyte activity

AIDS

Volumn 18, Issue 4, 2004, Pages 597-604

  Gamberg, Jane ^a   Barrett, Lisa ^a   Bowmer, M Ian ^a,b   Howley, Constance ^b   Grant, Michael ^a,c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Hlth Care Corporation of St John's   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Cytotoxic T lymphocytes; HAART; Highly active antiretroviral therapy; Immune memory; Virus load

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; NEF PROTEIN; POL PROTEIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIGENS, CD28; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE COUNT; MULTIVARIATE ANALYSIS; VIRUS REPLICATION;

EID: 1642353132     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200403050-00003     Document Type: Article

References (31)

1. Gamberg J, Grant M. Cytotoxic T lymphocytes in human immunodeficiency virus type-1 infection. Important or impotent? Clin Appl Immunol Rev 2000, 1:17-36.
2. Lieberman J, Shankar P, Manjunath N, Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001, 98:1667-1677.
3. Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, Kieny MP, Dreyfus F, Saimot AG, et al. Qualitative and quantitative analysis of human cytolytic T lymphocyte responses to HIV-1 proteins. AIDS 1992, 6:1249-1258.
4. Gamberg J, Bowmer M, Trahey J, Campbell C, Pardoe I, Grant M. Functional and genetic integrity of the CD8 T-cell repertoire in advanced HIV infection. AIDS 1999, 13:2043-2053.
5. Chouquet C, Autran B, Gomard E, Bouley J-M, Calvez V, Katlama C, et al. Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection. AIDS 2002, 16:2399-2407.
6. Harrigan P, Whaley M, Montaner J. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 1999, 13:F59-F62.
7. Kalams SA, Goulder PJ, Shea AK, Jones NC, Trocha AK, Ogg, GS, et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J Virol 1999, 73:6721-6728.
8. Ogg CS, Jin X, Bonhoeffer S, Moss P, Nowak MA, Monard S, et al. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 1999, 73:797-800.
9. Dalod M, Harzic M, Pellegrin I, Dumon B, Hoen B, Sereni D, et al. Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J Infect Dis 1998, 178:61-69.
10. Spiegel H, DeFalcon E, Ogg G, Larsson M, Beadle T, Tao P, et al. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children. J Infect Dis 1999, 180:359-368.
11. Hamann D, Baars P, Rep M, Hooibrink B, Kerkhof-Garde S, Klein M, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997, 186:1407-1418.
12. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
13. Champagne P, Ogg G, King A, Knabenhans C, Ellefsen K, Nobile M, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2000, 410:106-111.
14. Donaghy H, Pozniak A, Gazzard B, Qazi N, Gilmour J, Gotch F, et al. Loss of blood CD11c+ myeloid and CD11c-plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001, 98:2574-2576.
15. Rosenberg E, Billingsley J, Caliendo A, Boswell S, Sax P, Kalams S, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997, 278:1447-1450.
16. Sieg SF, Mitchem JB, Bazdar DA, Lederman MM. Close link between CD4+ and CD8+ T cell proliferation defects in patients with human immunodeficiency virus disease and relationship to extended periods of CD4+ lymphopenia. J Infect Dis 2002, 185:1401-1408.
17. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003, 187:1534-1543.
18. Lange CG, Lederman MM, Medvik K, Asaad R, Wild M, Kalayjian R, et al. Nadir CD4 T-cell count and numbers of CD28+CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS 2003, 17:2015-2023.
19. Autran B, Carcelain G, Li T, Blanc C, Mathez D, Tubiana R, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
20. Oxenius A, Fidler S, Brady M, Dawson S, Ruth K, Easterbrook P, et al. Variable fate of virus-specific CD4+ T cells during primary HIV-1 infection. Eur J Immunol 2001, 31:3782-3786.
21. Douek D, Brenchley J, Betts M, Ambrozak D, Hill B, Okamoto Y, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002, 417:95-98.
22. Chen R, Westfall A, Raper J, Cloud C, Chatham A, Acosta E, et al. Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice. AIDS Res Hum Retroviruses 2002, 18:909-916.
23. Ostrowski M, Justement S, Ehler L, Mizell S, Lui S, Mican J, et al. The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses. J Immunol 2000, 165:6133-6141.
24. Kalams S, Buchbinder S, Rosenberg E, Billingsley J, Colbert D, Jones N, et al. Association between virus-specific cytotoxic T lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol 1999, 73:6715-6720.
25. Rosenberg E, Altfeld M, Poon S, Phillips M, Wilkes B, Eldridge R, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000, 407:523-526.
26. Gea-Banacloche J, Migueles S, Martino L, Shupert W, McNeil A, Sabbaghian M, et al. Maintenance of large numbers of virus-specific CD8+T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 2000, 165:1082-1092.
27. Wodarz D. Helper-dependent vs helper-independent CTL responses in HIV infection: implications for drug therapy and resistance. J Theor Biol 2001, 213:447-459.
28. Wolthers K, Miedema F. Telomeres and HIV infection: in search of exhaustion. Trends Microbiol 1998, 6:144-147.
29. Effros R, Allsopp R, Chiu C, Hausner M, Hirji K, Wang L, et al. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996, 10:F17-F22.
30. Grant M, Pardoe I, Whaley M, Montaner J, Harrigan P. The T cell receptor Vβ repertoire shows little change during treatment interruption-related viral rebound in chronic HIV infection. AIDS 2002, 16:287-293.
31. Oxenius A, McLean AR, Fischer M, Price DA, Dawson SJ, Hafner R, et al. Human immunodeficiency virus-specific CD8+ T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy. J Virol 2002, 76:10169-10176.